TY - JOUR
T1 - Multi-scale semi-supervised clustering of brain images
T2 - Deriving disease subtypes
AU - Alzheimer's Disease Neuroimaging Initiative
AU - Wen, Junhao
AU - Varol, Erdem
AU - Sotiras, Aristeidis
AU - Yang, Zhijian
AU - Chand, Ganesh B.
AU - Erus, Guray
AU - Shou, Haochang
AU - Abdulkadir, Ahmed
AU - Hwang, Gyujoon
AU - Dwyer, Dominic B.
AU - Pigoni, Alessandro
AU - Dazzan, Paola
AU - Kahn, Rene S.
AU - Schnack, Hugo G.
AU - Zanetti, Marcus V.
AU - Meisenzahl, Eva
AU - Busatto, Geraldo F.
AU - Crespo-Facorro, Benedicto
AU - Rafael, Romero Garcia
AU - Pantelis, Christos
AU - Wood, Stephen J.
AU - Zhuo, Chuanjun
AU - Shinohara, Russell T.
AU - Fan, Yong
AU - Gur, Ruben C.
AU - Gur, Raquel E.
AU - Satterthwaite, Theodore D.
AU - Koutsouleris, Nikolaos
AU - Wolf, Daniel H.
AU - Davatzikos, Christos
N1 - Publisher Copyright:
© 2021 Elsevier B.V.
PY - 2022/1
Y1 - 2022/1
N2 - Disease heterogeneity is a significant obstacle to understanding pathological processes and delivering precision diagnostics and treatment. Clustering methods have gained popularity for stratifying patients into subpopulations (i.e., subtypes) of brain diseases using imaging data. However, unsupervised clustering approaches are often confounded by anatomical and functional variations not related to a disease or pathology of interest. Semi-supervised clustering techniques have been proposed to overcome this and, therefore, capture disease-specific patterns more effectively. An additional limitation of both unsupervised and semi-supervised conventional machine learning methods is that they typically model, learn and infer from data using a basis of feature sets pre-defined at a fixed anatomical or functional scale (e.g., atlas-based regions of interest). Herein we propose a novel method, “Multi-scAle heteroGeneity analysIs and Clustering” (MAGIC), to depict the multi-scale presentation of disease heterogeneity, which builds on a previously proposed semi-supervised clustering method, HYDRA. It derives multi-scale and clinically interpretable feature representations and exploits a double-cyclic optimization procedure to effectively drive identification of inter-scale-consistent disease subtypes. More importantly, to understand the conditions under which the clustering model can estimate true heterogeneity related to diseases, we conducted extensive and systematic semi-simulated experiments to evaluate the proposed method on a sizeable healthy control sample from the UK Biobank (N = 4403). We then applied MAGIC to imaging data from Alzheimer's disease (ADNI, N = 1728) and schizophrenia (PHENOM, N = 1166) patients to demonstrate its potential and challenges in dissecting the neuroanatomical heterogeneity of common brain diseases. Taken together, we aim to provide guidance regarding when such analyses can succeed or should be taken with caution. The code of the proposed method is publicly available at https://github.com/anbai106/MAGIC.
AB - Disease heterogeneity is a significant obstacle to understanding pathological processes and delivering precision diagnostics and treatment. Clustering methods have gained popularity for stratifying patients into subpopulations (i.e., subtypes) of brain diseases using imaging data. However, unsupervised clustering approaches are often confounded by anatomical and functional variations not related to a disease or pathology of interest. Semi-supervised clustering techniques have been proposed to overcome this and, therefore, capture disease-specific patterns more effectively. An additional limitation of both unsupervised and semi-supervised conventional machine learning methods is that they typically model, learn and infer from data using a basis of feature sets pre-defined at a fixed anatomical or functional scale (e.g., atlas-based regions of interest). Herein we propose a novel method, “Multi-scAle heteroGeneity analysIs and Clustering” (MAGIC), to depict the multi-scale presentation of disease heterogeneity, which builds on a previously proposed semi-supervised clustering method, HYDRA. It derives multi-scale and clinically interpretable feature representations and exploits a double-cyclic optimization procedure to effectively drive identification of inter-scale-consistent disease subtypes. More importantly, to understand the conditions under which the clustering model can estimate true heterogeneity related to diseases, we conducted extensive and systematic semi-simulated experiments to evaluate the proposed method on a sizeable healthy control sample from the UK Biobank (N = 4403). We then applied MAGIC to imaging data from Alzheimer's disease (ADNI, N = 1728) and schizophrenia (PHENOM, N = 1166) patients to demonstrate its potential and challenges in dissecting the neuroanatomical heterogeneity of common brain diseases. Taken together, we aim to provide guidance regarding when such analyses can succeed or should be taken with caution. The code of the proposed method is publicly available at https://github.com/anbai106/MAGIC.
KW - Clustering
KW - Heterogeneity
KW - Multi-scale
KW - Semi-simulated
KW - Semi-supervised
UR - http://www.scopus.com/inward/record.url?scp=85119419962&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85119419962&partnerID=8YFLogxK
U2 - 10.1016/j.media.2021.102304
DO - 10.1016/j.media.2021.102304
M3 - Article
C2 - 34818611
AN - SCOPUS:85119419962
SN - 1361-8415
VL - 75
JO - Medical Image Analysis
JF - Medical Image Analysis
M1 - 102304
ER -